Scholars Central

Research articlePublished 31 Dec 2016

Synthesis and Leishmanicidal Evaluation of 5-Arylidine-Immuno- Thiazolidine 4 one derivative: An In-Vitro study

Authors: Ali Fattahi Bafghi, Elham Rezaei, Hamid Nadri, Arefeh Dehghani

Journal of Chemical and Pharmaceutical Research

Volume 8 · Issue 12 · Pages 248–253

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Cutaneous Leishmaniasis (CL) is an endemic disease in developing countries. Glocantime has been recommended for CL treatment by W.H.O, there are some Restrictions in this case including high expense, side effects, frequent injections need, and incomplete efficacy. Cutaneous Leishmaniasis is an endemic disease in developing countries. Glocantime has been recommended for CL treatment by W.H.O, there are some Restrictions in this case including high expense, side effects, frequent injections need, and incomplete efficacy. The aim of the study was the efficacy of Synthesis and Leishmanicidal Evaluation of Aryl Immuno-5- Arylidine Thiazolidine 4- 1 derivative: An in vitro study. Materials and Methods: The design of the present probe was experimental (laboratory-trail); therefore, Iranian endemic species including Leishmania (L) tropica strain [MHOM/IR/NADIM3] was proliferated, and maintained in the standard culture. Then, the proper densities of Aryl Immuno-5- Arylidine Thiazolidine 4- 1 derivatives were provided and then sterilized and added to cultures containing parasite. Parasite numbers were counted in mentioned in cell proliferation ELISABrdu (Chemiluminescent). Results: Percentage of viability PMs Leishmania (L) tropica [MHOM/IR/NADIM3] in Concentrations of 1375, 2750, 5500 and 1100 mg/ml of 5-Arylidine-Immuno- Thiazolidine 4 one derivative and control showed statistically there was a significant difference, NOVA test, (P=0.000). And Percentage of viability PMs Leishmania (L) tropica [MHOM/IR/NADIM3] in Concentrations of 125, 250, 500 and 1000 mg/ml of Glocantime and control showed statistically there was a significant difference, ANOVA test, (P=0.000). Conclusion: According to the results, 5-Arylidine-Immuno- Thiazolidine 4 one derivative is effect and may make it possible to use them in the treatment of Cutaneous Leishmaniasis as a or alternative therapy; however, further studies are necessary and should be evaluated in cell culture and in vivo conditions to confirm it.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Chemical and Pharmaceutical Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Chemical and Pharmaceutical Research
  • SubjectPharmaceutical Sciences
  • SubjectChemistry
  • BylineArticles whose byline prints “Ali Fattahi Bafghi”
  • BylineArticles whose byline prints “Elham Rezaei”
  • BylineArticles whose byline prints “Hamid Nadri”
  • BylineArticles whose byline prints “Arefeh Dehghani”